Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CareRx Corp T.CRRX

Alternate Symbol(s):  CHHHF

CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It... see more

TSX:CRRX - Post Discussion

CareRx Corp > Ontario reimbursements
View:
Post by Possibleidiot01 on Feb 23, 2022 8:31am

Ontario reimbursements

Here's confirmation of a long term problem with the business model ; fortunately the stock price has MORE than discounted the fact customers ( governments) control the prices paid.

"Under certain amendments to the Ontario Drug Benefit Act that came into effect on January 1, 2020 , the reimbursement model for long-term care pharmacies in Ontario was changed from a fee-for-service model to a fee-per-bed capitation model under which pharmacies receive a fixed professional fee for all pharmacy services provided to residents in long-term care homes. The fee for 2020, which was prescribed at $1,500 per bed per year, was scheduled to decline to $1,400 per bed per year on April 1, 2021 . The step-down in capitation was previously postponed until April 1, 2022 and has now been postponed again until April 1, 2023 ."

Gives the company more time to automate operations before the fee reduction.
Comment by prophetoffacts on Feb 23, 2022 1:00pm
This post has been removed in accordance with Community Policy
Comment by MrMugsy on Feb 24, 2022 7:05pm
Which is probably why you want to add some non-drug sales (higher margin play) to this puppy - enter Revicare. Would like to see the details on this one.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities